Clinical Experience
WONG Weng Chun, ZENG Luo Xin
Objective This study is based on the BEERS and STOPP criteria, combined with the
actual medication usage at Kiang Wu Hospital (KWH), Macao, to develop a
comprehensive list of potentially inappropriate medication (PIM) screening
items. It analyzes the PIM use in hospitalized elderly patients aged 80 or above in the internal medicine department of KWH
and explores the associated risk factors. Methods A retrospective cohort study design was adopted, collecting data from
hospitalized internal medicine patients aged 80 years or older in KWH between January 1, 2023, and December 31,
2023. Data included demographics,
comorbidities, physiological factors, and medication use. PIM screening was
performed based on the 2023 version of the BEERS and
STOPP criteria, and the risk factors for PIM use were explored using
multivariate logistic regression analysis. Results The screening rates based on STOPP and BEERS criteria were 96.93% and 91.73%, respectively, and the mean
number of PIMs per capita was 3.53±1.95 and
3.16±1.86, respectively (P<0.001).
The most common reasons for PIM were the use of medications requiring caution,
central nervous system drugs, and drugs that increase the risk of falls.
Multivariate regression analysis revealed that, compared to mild PIM, the risk
factors for moderate PIM based on the BEERS criteria were diabetes, gout, and
hyperuricemia; the risk factor for severe PIM was peripheral vascular embolism;
and the common risk factors for moderate and severe PIM were depression and
anxiety, as well as a hospital stay longer than 20 days. Based on the STOPP criteria, the risk factors for moderate PIM
compared to mild PIM were having more than five chronic diseases, peripheral
vascular embolism, and a hospital stay longer than 20 days; the common risk
factors for moderate and severe PIM were heart failure, osteoporosis, and a
history of fractures. Conclusion Managing medications in elderly patients presents unique challenges,
with PIMs being particularly prevalent. Effective clinical management requires
a comprehensive approach that considers individual variations, comorbid
conditions, and drug-specific factors. Priority should be given to addressing
modifiable risk factors (e.g., extended hospital stays) while maintaining
vigilant monitoring of non-modifiable factors (e.g., multiple comorbidities). A
three-tiered intervention strategy is recommended: (1) regular medication
regimen reviews, (2) selection of safer therapeutic alternatives when
available, and (3) implementation of personalized monitoring protocols for
high-risk medications. Successful implementation requires close collaboration
between physicians and pharmacists, coupled with the integration of a
severity-based PIM classification system into electronic health records to
systematically enhance medication safety.